Hereditary cancer
PRINCIPAL INVESTIGATORS
- Joan Maria Brunet Vidal
- Marta Pineda Riu
- Laura Valle Velasco
- Barbara Rivera Polo
CLINICAL RESEARCHERS
- Agostina Stradella
- Alexandre Teule Vega
POSTDOCTORAL RESEARCHERS
- Jacopo Boni
- Ana Filipa Brinco De Oliveira Ponte
- Paula Climent Cantó
- Sara Crespo Yanguas
- Jesus Del Valle Dominguez
- Maria Lídia Feliubadaló Elorza
- Juana Fernández Rodríguez
- Noemí González Abuín
- Fátima Marín Nieto
- Mireia Morell Ginesta
- Mariona Terradas Ill
PREDOCTORAL RESEARCHERS
- Julia Canet Hermida
- Anne Sophie Chong
- Edgar Creus Bachiller
- Nuria Dueñas Cid
- Hyerim Han
- Demetra Kyriacou
- Jose Marcos Moreno Cabrera
- Elisabet Munte Roca
- Sara Ortega Bertran
- Isabel Quintana Gallardo
- Carla Roca Grau
- Paula Rofes Terrón
- Manuel Torralba Carnerero
- Julen Viana Errasti
SCIENTIFIC SUPPORT
- Gemma Aiza Buscarons
- Miriam Fernandez Gonzalez
- Clara Nogué Ansón
- Mireia Ramos Muntada
- Cristina Rioja Llerena
- Lluis Salvador Hernandez
MANAGEMENT SUPPORT
- Patricia Prada Dacasa
- Iolanda Rubio Carre
Cancer
Oncobell
Scientific production
41
PAPERS
Average IF: 5,336
12
LED PAPERS
Average IF: 6,304
9 PUBLICATIONS IN FIRST DECILE
28 PUBLICATIONS IN FIRST QUARTILE
25 PUBLICATIONS IN OPEN ACCESS
Selected publications
- Nogué C, Chong AS, Grau E, Han H, Dorca E, Roca C, Mosquera JL, Lázaro C, Foulkes WD, Brunet J, Rivera B. DGCR8 and the six hit, three-step model of schwannomatosis. Acta Neuropathol. 2022;143(1):115-117. doi:10.1007/s00401-021-02387-z.
- Quintana I, Mur P, Terradas M, Garcia Mulero S, Aiza G, Navarro M, Pinol V, Brunet J, Moreno V, Sanz Pamplona R, Capella G, Valle L. Potential Involvement of NSD1, KRT24 and ACACA in the Genetic Predisposition to Colorectal Cancer. Cancers. 2022;14(3):doi:10.3390/cancers14030699.
- Fernández Rodríguez J, Creus Bachiller E, Zhang X, Martínez Iniesta M, Ortega Bertran S, Guha R, Thomas CJ, Wallace MR, Romagosa C, Salazar Huayna L, Reilly KM, Blakeley JO, Serra Musach J, Pujana MA, Serra E, Villanueva A, Ferrer M, Lázaro C. A high-throughput screening platform identifies novel combination treatments for Malignant Peripheral Nerve Sheath Tumors. Mol. Cancer Ther. 2022;21(7):1246-1258. doi:10.1158/1535-7163.MCT-21-0947.
- Morak M, Pineda M, Martins A, Gaildrat P, Tubeuf H, Drouet A, Gómez C, Dámaso E, Schaefer K, Steinke Lange V, Koehler U, Laner A, Hauchard J, Chauris K, Holinski Feder E, Capellá G. Splicing analyses for variants in MMR genes: best practice recommendations from the European Mismatch Repair Working Group. Eur. J. Hum. Genet. 2022;30(9):1051-1059. doi:10.1038/s41431-022-01106-w.
- Boni J, Idani A, Roca C, Feliubadaló L, Tomiak E, Weber E, Foulkes WD, Orthwein A, El Haffaf Z, Lazaro C, Rivera B. A decade of RAD51C and RAD51D germline variants in cancer. HUM MUTAT. 2022;43(3):285-298. doi:10.1002/humu.24319.
Research highlights
PROJECTS
6 Granted competitive projects
37 Ongoing competitive projects
2 Started clinical trials
37 Ongoing clinical trials
1 Started non-competitive projects
1 Ongoing non-competitive projects
PUBLISHED WORKS
3 theses
2 Clinical guidelines
NETWORKS
AGAUR SGR GRC
C4CMMRD
CIMBA
ClinGen
COMPLEXO
EHTG
ENIGMA
ERN GENTURIS
IRRDC
Network for Rare Tumors of the Ovary
Solve-RD
CIBERONC
CRECE
IMPACT Genómica
INGENIO
SPADA – Spanish Variant Database
AGAUR 2017 SGR 1282
Int.W.G. on early-onset colorectal cancer
Selected projects
- “MCI21007 . POLYMERASE PROOFREADING-DEFICIENT TUMORS: GENETICS AND IMMUNE BIOLOGY INSIGHTS FOR IMPROVED PREDICTIVE MEDICINE (PROOFREAD4MED. TUMORES DEFICIENTES EN LA CORRECCIÓN DE ERRORES DE LAS POLIMERASAS: PROFUNDIZANDO EN SUS BASES GENÉTICAS Y BIOLOGÍA INMUNE PARA MEJORAR LAS RECOMENDACIONES CLÍNICAS (PROOFREAD4MED). Ministerio de Ciencia e Innovación. Budget: 393250. 2022-2025. PI: Valle Velasco, Laura.”
- 19INT004. The mechanistic basis for constitutional MLH1 methylation (epimutation). NATIONAL INSTITUTES OF HEALTH NIH. Budget: 288872,48. 2019-2023. PI: Capellá Munar, Gabriel.
- INT21018. NF1 nonsense suppression by targeted pseudouridylation. GILBERT FAMILY FOUNDATION. Budget: 266523,46. 2022-2024. PI: Lázaro García, Concepción.
- USA20001. Network for Rare Tumors of the Ovary (NRTO). DEPARTMENT OF DEFENSE. Budget: 182983,05. 2021-2024. PI: Rivera Polo, Barbara.
- 21MAR003. Characterizing early events driving carcinogenesis in Constitutional Mismatch Repair Deficiency (CMMRD) syndrome as a potential strategy for precision surveillance and prevention. Fundació La Marató de TV3. Budget: 177754,69. 2021-2024. PI: Pineda Riu, Marta.